World News: 14:30 GMT Monday 16th April 2018. [Fate Therapeutics, Inc. via Globe Newswire via SPi World News]
SAN DIEGO April 16 2018 GLOBE NEWSWIRE -- Fate Therapeutics Inc NASDAQFATE a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders announced today th at the ...
Globe Newswire: 14:30 GMT Monday 16th April 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.